레비티 (RVTY) 주가

레비티(RVTY)는 NYSE에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $143.45 (-2.24%), 시가총액 $10.75B, PER (주가수익비율) 46.34, 52주 최저~최고 $82.26 ~ $117.75.

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable

핵심 지표

• 현재가: $143.45 (-2.24%)
• 시가총액: $10.75B
• PER (주가수익비율): 46.34
• 52주 최저~최고: $82.26 ~ $117.75
• 섹터: Healthcare
• 산업: Diagnostics & Research
• 거래소: NYSE

레비티의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

레비티 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.1579

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 1.57
• 순이익률: 0.08%
• 영업이익률: 0.12%
• 배당수익률: 0.00%

자주 묻는 질문